vimarsana.com
Home
Live Updates
Axsome Therapeutics Presents Data from Multiple Programs at the 2024 American Society of ... : comparemela.com
Axsome Therapeutics Presents Data from Multiple Programs at the 2024 American Society of ...
NEW YORK, May 28, 2024 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company developing and delivering novel therapies for the management of central nervous system (CNS) disorders,
Related Keywords
New York ,
United States ,
Florida ,
Miami Beach ,
Toronto ,
Ontario ,
Canada ,
American ,
Roger Mcintyre ,
Jeffrey Cummings ,
Harryl Smith ,
Andrew Muzyk ,
Darren Opland ,
David Gozal ,
Mark Jacobson ,
Department Of Brain Health ,
Axsome Therapeutics Inc ,
Drug Administration ,
University Of Toronto ,
Nasdaq ,
Corporate Communications ,
Development Program ,
Department Of Child Health ,
American Society Of Clinical Psychopharmacology ,
World Trade Center ,
University Of Missouri ,
Clinical Psychopharmacology ,
Annual Meeting ,
Improving Anhedonia ,
Interest Activity Symptoms ,
Associated Improvements ,
Major Depressive ,
Associate Professor ,
Medical Education ,
Clinical Profile ,
Treating Alzheimer ,
Disease Agitation ,
Results From The Phase ,
Vice Chair ,
Solriamfetol Improves Cognitive Performance ,
Preclinical Models ,
Sleep Apnea ,
Randomized Placebo Controlled Study ,
Sleep Apnea Participants ,
Endowed Chair ,
Child Health ,
Breakthrough Therapy ,
Prescribing Information ,
Boxed Warning ,
Axsome Therapeutics ,
comparemela.com © 2020. All Rights Reserved.